Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-02-14 4:55 pm Sale | 13G | REVANCE THERAPEUTICS INC RVNC | Palo Alto Investors LP | 5,237,284 5.96% | -46,325 (-0.88%) | View |
2024-02-14 4:54 pm Purchase | 13G | EHEALTH, INC. EHTH | Palo Alto Investors LP | 2,739,379 9.66% | 254,900 (+10.26%) | View |
2024-02-14 4:52 pm Sale | 13G | KARYOPHARM THERAPEUTICS INC KPTI | Palo Alto Investors LP | 5,102,193 4.45% | -553,483 (-9.79%) | View |
2023-04-03 2:24 pm Sale | 13G | ALIMERA SCIENCES INC ALIM | Palo Alto Investors LP | 0 0% | -802,423 (Position Closed) | View |
2023-02-14 4:23 pm Sale | 13G | VANDA PHARMACEUTICALS INC VNDA | Palo Alto Investors LP | 1,087,064 1.42% | -1,747,180 (-61.65%) | View |
2023-02-14 4:22 pm Purchase | 13G | REVANCE THERAPEUTICS INC RVNC | Palo Alto Investors LP | 5,283,609 6.42% | 914,243 (+20.92%) | View |
2023-02-14 4:21 pm Purchase | 13G | KARYOPHARM THERAPEUTICS INC KPTI | Palo Alto Investors LP | 5,655,676 5% | 185,224 (+3.39%) | View |
2023-02-14 4:19 pm Sale | 13G | INSMED INC- INSM | Palo Alto Investors LP | 5,871,291 4.33% | -154,415 (-2.56%) | View |
2023-02-14 4:18 pm Sale | 13G | EPIZYME INC EPZM | Palo Alto Investors LP | 0 0% | -5,485,213 (Position Closed) | View |
2023-02-14 4:17 pm Purchase | 13G | EHEALTH, INC. EHTH | Palo Alto Investors LP | 2,484,479 9.06% | 868,909 (+53.78%) | View |
2023-02-14 4:12 pm Unchanged | 13G | ALIMERA SCIENCES INC ALIM | Palo Alto Investors LP | 802,423 11.45% | 0 (Unchanged) | View |
2022-02-14 5:11 pm Sale | 13G | EPIZYME INC EPZM | Palo Alto Investors LP | 5,485,213 5.28% | -1,253,700 (-18.60%) | View |
2022-02-14 5:09 pm Purchase | 13G | KARYOPHARM THERAPEUTICS INC KPTI | Palo Alto Investors LP | 5,470,452 7.24% | 202,800 (+3.85%) | View |
2022-02-14 5:08 pm Sale | 13G | VANDA PHARMACEUTICALS INC VNDA | Palo Alto Investors LP | 2,834,244 5.09% | -1,396,304 (-33.01%) | View |
2022-02-14 5:07 pm Purchase | 13G | ALIMERA SCIENCES INC ALIM | Palo Alto Investors LP | 802,423 11.57% | 802,423 (New Position) | View |
2022-02-14 5:04 pm Purchase | 13G | REVANCE THERAPEUTICS INC RVNC | Palo Alto Investors LP | 4,369,366 6.09% | 4,369,366 (New Position) | View |
2022-02-14 5:03 pm Sale | 13G | STAAR SURGICAL CO STAA | Palo Alto Investors LP | 1,140,511 2.4% | -1,708,837 (-59.97%) | View |
2022-02-14 5:01 pm Sale | 13G | INSMED INC- INSM | Palo Alto Investors LP | 6,025,706 5.09% | -80,274 (-1.31%) | View |
2022-02-14 4:59 pm Sale | 13G | CLOVIS ONCOLOGY INC CLVS | Palo Alto Investors LP | 3,997,826 3.08% | -471,585 (-10.55%) | View |
2022-02-14 4:57 pm Purchase | 13G | EHEALTH, INC. EHTH | Palo Alto Investors LP | 1,615,570 6.12% | 1,615,570 (New Position) | View |